LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Handheld Blood Gas Electrolyte Analyzer Advances Point-of-Care Testing (POCT)

By LabMedica International staff writers
Posted on 04 Jul 2023
Print article
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centered healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes. Now, a new handheld blood gas electrolyte analyzer designed to meet the urgency of clinical decision provides prompt POCT and improves patient outcomes while reducing therapeutic turnaround time (TTAT) and shortening door-to-clinical-decision time.

The newly-launched i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopts microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers. Furthermore, special production technology enables its long-term stability to last 12 months under refrigeration. The i-Check handheld blood gas electrolyte analyzer requires only 95 μL of blood to measure pH, PCO2, PO2, K, Na, iCa, Hct, etc. in just one minute.

Among other benefits, the cartridge can be used immediately after removal from the refrigerator and does not need to be brought up to room temperature due to the efficient heating effect of the attached carbon heating film. It can rapidly increase the temperature of the electrode and flow path and maintain them at 37℃ when paired with an IR temperature sensor. Each cartridge has its own standard solution (calibrator), facilitating a one-point calibration, and eliminating the need for an additional reagent package. Calibration before sample injection is performed to prevent the impact of blood cell precipitation on Hct testing. Each cartridge also contains a unique RFID chip for quality control, effectively avoiding erroneous results from using expired cartridges. In a correlation experiment with a desktop blood gas analyzer, the i-Check excelled in test performance with correlation coefficients R2 all above 0.973 (n=76).

Related Links:
B&E Biotechnology Co. Ltd. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crytal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more